Protection of normal cells
US8487128B2 · kind B2 · utility
31Cited by
4References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 2008 |
| Grant date | Jul 16, 2013 |
| Priority date | — |
| Expiry date | Feb 25, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions comprising sulindac, R-epimer sulindac, S-epimer sulindac, derivatives, metabolites, and structural analogs thereof which protect normal cells against damage caused by solar rays, oxidative damage, environmental factors, diseases and organisms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.